XBI ETF — Holdings & Market Internals
A visuals-first look inside State Street SPDR S&P Biotech ETF (XBI): a weight-sized holdings treemap, sector concentration, and the breadth oscillators that reveal whether the fund's move is broad or narrow — built on the live 157-name holdings snapshot.
Historical breadth is computed against the current XBI membership, so older values carry a degree of survivorship bias (constituents removed from the fund are excluded from past readings).
Holdings Treemap
Tile size = ETF weight, grouped by sector. Color by:
Sector Weights
Share of the fund by GICS-style sector.
Market Breadth Snapshot
How many constituents are participating in the trend. See the full internals →
Trend Alignment
Cap-weighted share of the fund by where price sits across its 20/50/200-day SMAs — 44% is in full alignment.
Valuation & Fundamentals
Sector multiples and dispersion across holdings (cap-weighted harmonic mean). Full valuation →
Valuation by Sector & Distribution
Fund P/E: 19.5 — cap-weighted harmonic mean. Green = cheaper than the fund.
By sector (cap-weighted)
Distribution across holdings
One-Month Leaders
Strongest constituents over the trailing month.
One-Month Laggards
Weakest constituents — candidates for the opportunity scan.
Holdings Explorer
Top 30 by weight — sort any column. View all 157 holdings →
| MRNA | Moderna, Inc. Common Stock | Health Care | 2.55% | $217.50 | -3.51% | -0.94% | +244.84% | 50 | 100 | $91.2B |
| EXEL | Exelixis Inc | Health Care | 1.79% | $68.35 | -1.22% | +11.85% | +34.63% | 59 | 96 | $17.6B |
| AMGN | Amgen Inc | Health Care | 1.78% | $464.55 | -0.32% | +6.85% | +12.76% | 62 | 92 | $249.4B |
| BIIB | Biogen Inc. Common Stock | Health Care | 1.78% | $254.61 | +1.21% | +7.16% | +21.62% | 59 | 96 | $36.8B |
| SYRE | Spyre Therapeutics, Inc. Common Stock | Health Care | 1.77% | $104.00 | +1.07% | +35.29% | +1.03% | 59 | 100 | $9.3B |
| TGTX | TG Therapeutics, Inc. | Health Care | 1.77% | $63.66 | -0.15% | +17.04% | +32.36% | 65 | 98 | $9.3B |
| REGN | Regeneron Pharmaceuticals Inc | Health Care | 1.76% | $957.03 | +0.47% | +19.09% | +19.17% | 68 | 93 | $100.7B |
| ABBV | ABBVIE INC. | Health Care | 1.75% | $294.79 | -0.31% | +2.34% | +18.25% | 63 | 90 | $505.4B |
| UTHR | United Therapeutics Corp | Health Care | 1.75% | $591.25 | -0.45% | +8.42% | +17.69% | 58 | 90 | $25.8B |
| GILD | Gilead Sciences Inc | Health Care | 1.73% | $167.22 | +0.05% | +7.47% | +21.48% | 59 | 92 | $207.7B |
| ORKA | Oruka Therapeutics, Inc. Common Stock | Health Care | 1.72% | $105.34 | +0.36% | +39.48% | -4.42% | 64 | 100 | $6.6B |
| NBIX | Neurocrine Biosciences Inc | Health Care | 1.63% | $163.34 | -1.22% | +21.96% | +10.41% | 64 | 78 | $16.8B |
| VRTX | Vertex Pharmaceuticals Inc | Health Care | 1.56% | $535.84 | -0.75% | +4.60% | +6.89% | 53 | 88 | $134.5B |
| ALKS | Alkermes Inc. plc | Health Care | 1.55% | $47.02 | +0.06% | +18.34% | -3.81% | 62 | 97 | $7.7B |
| BBIO | BridgeBio Pharma, Inc. Common Stock | Health Care | 1.54% | $78.30 | +0.15% | +19.23% | -1.07% | 65 | 83 | $14.4B |
| NTRA | Natera, Inc. Common Stock | Health Care | 1.46% | $318.40 | -1.12% | -18.16% | +2.77% | 34 | 95 | $56.0B |
| INCY | Incyte Genomics Inc | Health Care | 1.45% | $120.82 | -0.61% | +7.33% | +0.67% | 54 | 76 | $24.0B |
| ROIV | Roivant Sciences Ltd. Common Shares | Health Care | 1.43% | $39.69 | -1.18% | +16.88% | +9.14% | 57 | 98 | $26.0B |
| PRAX | Praxis Precision Medicines, Inc. Common Stock | Health Care | 1.41% | $322.59 | +0.98% | +33.78% | -11.79% | 61 | 97 | $7.8B |
| KOD | Kodiak Sciences Inc Common Stock | Health Care | 1.41% | $110.50 | +2.51% | +36.77% | +174.07% | 69 | 100 | $6.2B |
| PTCT | PTC Therapeutics, Inc. | Health Care | 1.40% | $63.48 | +0.18% | +3.95% | -11.45% | 49 | 41 | $5.7B |
| HALO | Halozyme Therapeutics, Inc. | Health Care | 1.40% | $100.29 | -0.37% | -15.28% | +1.43% | 27 | 93 | $14.6B |
| PTGX | Protagonist Therapeutics, Inc | Health Care | 1.38% | $130.90 | -2.66% | -4.22% | -15.58% | 39 | 95 | $9.1B |
| KYMR | Kymera Therapeutics, Inc. Common Stock | Health Care | 1.38% | $127.61 | +0.38% | +19.50% | +8.67% | 55 | 98 | $10.8B |
| INSM | Insmed, Inc. | Health Care | 1.37% | $120.39 | +2.60% | +22.06% | -2.85% | 65 | 32 | $22.9B |
| TWST | Twist Bioscience Corporation Common Stock | Health Care | 1.36% | $110.20 | -2.30% | -19.18% | -4.54% | 38 | 100 | $9.3B |
| ERAS | Erasca, Inc. Common Stock | Health Care | 1.34% | $15.40 | -0.79% | +6.46% | -14.80% | 54 | 100 | $5.1B |
| RYTM | Rhythm Pharmaceuticals, Inc. Common Stock | Health Care | 1.32% | $114.40 | +4.78% | +30.10% | -0.33% | 66 | 80 | $6.0B |
| BMRN | BioMarin Pharmaceuticals Inc | Health Care | 1.32% | $57.24 | +0.90% | +1.38% | -14.58% | 50 | 63 | $10.8B |
| KRYS | Krystal Biotech, Inc. Common Stock | Health Care | 1.31% | $307.50 | -0.24% | -8.33% | -7.59% | 43 | 95 | $9.0B |